Prestige Consumer Healthcare Total Assets Growth & History (PBH)
Prestige Consumer Healthcare's total assets was $3.49B for fiscal 2026.
View full Prestige Consumer Healthcare company overviewPrestige Consumer Healthcare annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $3.49B | $92.1M | +2.71% |
| 2025 | 2025-03-31 | $3.40B | $83.8M | +2.53% |
| 2024 | 2024-03-31 | $3.32B | −$35.3M | −1.05% |
| 2023 | 2023-03-31 | $3.35B | −$317.0M | −8.63% |
| 2022 | 2022-03-31 | $3.67B | $241.4M | +7.04% |
| 2021 | 2021-03-31 | $3.43B | −$84.6M | −2.41% |
| 2020 | 2020-03-31 | $3.51B | $72.9M | +2.12% |
| 2019 | 2019-03-31 | $3.44B | −$319.6M | −8.50% |
| 2018 | 2018-03-31 | $3.76B | −$150.7M | −3.85% |
| 2017 | 2017-03-31 | $3.91B | $962.6M | +32.64% |
| 2016 | 2016-03-31 | $2.95B | $306.8M | +11.61% |
| 2015 | 2015-03-31 | $2.64B | $846.3M | +47.13% |
| 2014 | 2014-03-31 | $1.80B | $55.9M | +3.21% |
| 2013 | 2013-03-31 | $1.74B | −$18.5M | −1.05% |
| 2012 | 2012-03-31 | $1.76B | $701.4M | +66.36% |
| 2011 | 2011-03-31 | $1.06B | — | — |
Prestige Consumer Healthcare quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $4.57B | $1.14B | +33.13% |
| Q4 2026 | 2026-03-31 | $3.49B | $92.1M | +2.71% |
| Q3 2026 | 2025-12-31 | $3.49B | $165.2M | +4.96% |
| Q2 2026 | 2025-09-30 | $3.44B | $125.4M | +3.78% |
| Q1 2026 | 2025-06-30 | $3.43B | $124.1M | +3.75% |
| Q4 2025 | 2025-03-31 | $3.40B | $83.8M | +2.53% |
| Q3 2025 | 2024-12-31 | $3.33B | −$10.3M | −0.31% |
| Q2 2025 | 2024-09-30 | $3.32B | −$16.0M | −0.48% |
| Q1 2025 | 2024-06-30 | $3.31B | −$38.1M | −1.14% |
| Q4 2024 | 2024-03-31 | $3.32B | −$35.3M | −1.05% |
| Q3 2024 | 2023-12-31 | $3.34B | −$410.0M | −10.93% |
| Q2 2024 | 2023-09-30 | $3.33B | −$345.6M | −9.40% |
| Q1 2024 | 2023-06-30 | $3.35B | −$336.7M | −9.14% |
| Q4 2023 | 2023-03-31 | $3.35B | −$317.0M | −8.63% |
| Q3 2023 | 2022-12-31 | $3.75B | $90.4M | +2.47% |
| Q2 2023 | 2022-09-30 | $3.68B | $2.7M | +0.07% |
| Q1 2023 | 2022-06-30 | $3.68B | $123.1M | +3.46% |
| Q4 2022 | 2022-03-31 | $3.67B | $241.4M | +7.04% |
| Q3 2022 | 2021-12-31 | $3.66B | $190.6M | +5.50% |
| Q2 2022 | 2021-09-30 | $3.68B | $241.5M | +7.03% |
| Q1 2022 | 2021-06-30 | $3.56B | $109.0M | +3.16% |
| Q4 2021 | 2021-03-31 | $3.43B | −$84.6M | −2.41% |
| Q3 2021 | 2020-12-31 | $3.47B | $4.6M | +0.13% |
| Q2 2021 | 2020-09-30 | $3.43B | −$30.5M | −0.88% |
| Q1 2021 | 2020-06-30 | $3.45B | −$10.6M | −0.31% |
| Q4 2020 | 2020-03-31 | $3.51B | $72.9M | +2.12% |
| Q3 2020 | 2019-12-31 | $3.46B | −$203.9M | −5.56% |
| Q2 2020 | 2019-09-30 | $3.46B | −$232.9M | −6.30% |
| Q1 2020 | 2019-06-30 | $3.46B | −$308.0M | −8.17% |
| Q4 2019 | 2019-03-31 | $3.44B | −$319.6M | −8.50% |
| Q3 2019 | 2018-12-31 | $3.67B | −$229.8M | −5.90% |
| Q2 2019 | 2018-09-30 | $3.70B | −$204.5M | −5.24% |
| Q1 2019 | 2018-06-30 | $3.77B | −$130.8M | −3.36% |
| Q4 2018 | 2018-03-31 | $3.76B | −$150.7M | −3.85% |
| Q3 2018 | 2017-12-31 | $3.90B | $1.09B | +38.67% |
| Q2 2018 | 2017-09-30 | $3.90B | $1.07B | +37.84% |
| Q1 2018 | 2017-06-30 | $3.90B | $1.02B | +35.47% |
| Q4 2017 | 2017-03-31 | $3.91B | $962.6M | +32.64% |
| Q3 2017 | 2016-12-31 | $2.81B | $169.9M | +6.43% |
| Q2 2017 | 2016-09-30 | $2.83B | $204.1M | +7.77% |
| Q1 2017 | 2016-06-30 | $2.88B | $241.9M | +9.18% |
| Q4 2016 | 2016-03-31 | $2.95B | $306.8M | +11.61% |
| Q3 2016 | 2015-12-31 | $2.64B | −$39.6M | −1.48% |
| Q2 2016 | 2015-09-30 | $2.63B | −$98.8M | −3.62% |
| Q1 2016 | 2015-06-30 | $2.64B | $782.6M | +42.21% |
| Q4 2015 | 2015-03-31 | $2.64B | $846.3M | +47.13% |
| Q3 2015 | 2014-12-31 | $2.68B | $815.8M | +43.74% |
| Q2 2015 | 2014-09-30 | $2.73B | $917.6M | +50.75% |
| Q1 2015 | 2014-06-30 | $1.85B | $117.9M | +6.79% |
| Q4 2014 | 2014-03-31 | $1.80B | $55.9M | +3.21% |
| Q3 2014 | 2013-12-31 | $1.86B | $133.5M | +7.71% |
| Q2 2014 | 2013-09-30 | $1.81B | $20.5M | +1.14% |
| Q1 2014 | 2013-06-30 | $1.74B | −$16.6M | −0.94% |
| Q4 2013 | 2013-03-31 | $1.74B | −$18.5M | −1.05% |
| Q3 2013 | 2012-12-31 | $1.73B | $685.5M | +65.55% |
| Q2 2013 | 2012-09-30 | $1.79B | $732.5M | +69.42% |
| Q1 2013 | 2012-06-30 | $1.75B | $704.0M | +67.14% |
| Q4 2012 | 2012-03-31 | $1.76B | $701.4M | +66.36% |
| Q3 2012 | 2011-12-31 | $1.05B | — | — |
| Q2 2012 | 2011-09-30 | $1.06B | — | — |
| Q1 2012 | 2011-06-30 | $1.05B | — | — |
| Q4 2011 | 2011-03-31 | $1.06B | — | — |
Prestige Consumer Healthcare total assets trends
Over the last five fiscal years, Prestige Consumer Healthcare's total assets increased from $3.43B to $3.49B, a change of $65.0M. The latest reported quarter, Q1 2027, shows $4.57B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prestige Consumer Healthcare source filings ↗